SNORD14E: A Potential Drug Target and Biomarker (G85391)

Target Name: SNORD14E

NCBI ID: G85391

SNORD14E

Other Name(s): small nucleolar RNA, C/D box 14E | Small nucleolar RNA, C/D box 14E

SNORD14E: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a class of non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the most well-known snRNAs is SNORD14E, which is located in the C/D box 14E of the 28S rRNA molecule.

The C/D box 14E region of the 28S rRNA molecule is a highly conserved region that is involved in the formation of a complex with the protein Snorc. Snorc is a key regulator of rRNA secondary structure and plays a crucial role in the regulation of gene expression. The C/D box 14E region is a critical region for the formation of this complex and is involved in the regulation of rRNA structure and stability.

SNORD14E is a small RNA molecule that contains 29 amino acid residues and has a calculated molecular weight of 30 kDa. It is highly conserved, with only one known isoform. SNORD14E is expressed in a variety of tissues and cells, including muscle, heart, and brain. It is also highly expressed in the tests, which suggests that it may be involved in the regulation of reproductive biology.

The function of SNORD14E is not well understood, but it is possible that it plays a role in the regulation of rRNA structure and stability. Several studies have suggested that SNORD14E may be involved in the regulation of rRNA secondary structure, including the formation of tRNAJ and the regulation of rRNA stability.

In addition to its potential role in the regulation of rRNA structure and stability, SNORD14E may also be involved in the regulation of gene expression. Several studies have suggested that SNORD14E may be involved in the regulation of gene expression in various organisms, including bacteria and yeast.

The potential drug targets for SNORD14E are currently being explored for its potential utility as a therapeutic agent. One potential mechanism by which SNORD14E may be involved in the regulation of gene expression is by regulating the stability of rRNA secondary structure. By regulating the stability of rRNA secondary structure, SNORD14E may be able to regulate the expression of genes that are critical for cell survival and growth.

Another potential mechanism by which SNORD14E may be involved in the regulation of gene expression is by regulating the translation of mRNA into protein. Translation into protein is the last step of gene expression, and the role of SNORD14E in the formation of rRNA secondary structure is speculated. Also involved in the translation of mRNA. By regulating the stability of rRNA secondary structure, SNORD14E may affect the translation efficiency of mRNA, thereby affecting intracellular protein synthesis.

In addition, the level of SNORD14E may also be used as a biomarker to measure drug efficacy. By detecting the content of SNORD14E, the inhibitory effect of drugs on SNORD14E can be evaluated, thereby providing valuable information for drug development.

In summary, SNORD14E is a drug target worthy of further study. By regulating the formation of rRNA secondary structures, SNORD14E may have important effects on gene expression and cell survival. By studying the function of SNORD14E, we can provide an important theoretical basis for the development of new drugs.

Protein Name: Small Nucleolar RNA, C/D Box 14E

The "SNORD14E Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD14E comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets